← Back to Screener
TransMedics Group, Inc. Common Stock (TMDX)
Price$109.12
Favorite Metrics
Price vs S&P 500 (26W)-5.64%
Price vs S&P 500 (4W)-3.26%
Market Capitalization$3.98B
P/E Ratio (Annual)20.93x
All Metrics
P/CF (Annual)20.65x
Book Value / Share (Quarterly)$13.81
P/TBV (Annual)8.82x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)86.42%
Cash Flow / Share (Quarterly)$3.90
Price vs S&P 500 (YTD)-7.20%
Gross Margin (TTM)59.92%
Net Profit Margin (TTM)31.43%
EPS (TTM)$4.68
10-Day Avg Trading Volume0.75M
EPS Excl Extra (TTM)$4.68
Revenue Growth (5Y)88.21%
EPS (Annual)$4.69
ROI (Annual)19.31%
Gross Margin (Annual)59.92%
Net Profit Margin (5Y Avg)-31.16%
Cash / Share (Quarterly)$14.25
P/E Basic Excl Extra (TTM)20.93x
Revenue Growth QoQ (YoY)32.18%
P/E Normalized (Annual)20.93x
ROA (Last FY)17.81%
Revenue Growth TTM (YoY)37.13%
EBITD / Share (TTM)$2.69
ROE (5Y Avg)-9.39%
Operating Margin (TTM)17.93%
Cash Flow / Share (Annual)$3.90
P/B Ratio8.42x
P/B Ratio (Quarterly)8.79x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)6.62x
Net Interest Coverage (TTM)78.80x
ROA (TTM)20.34%
EPS Growth QoQ (YoY)1213.57%
EV / EBITDA (TTM)36.69x
EPS Incl Extra (Annual)$4.69
Current Ratio (Annual)7.14x
Quick Ratio (Quarterly)6.41x
3-Month Avg Trading Volume0.82M
52-Week Price Return33.71%
EV / Free Cash Flow (Annual)29.99x
P/E Incl Extra (TTM)20.93x
Revenue / Employee (TTM)$1
Tangible BV / Share (Quarterly)$13.75
P/S Ratio (Annual)6.58x
Asset Turnover (Annual)0.57x
52-Week High$156.00
Operating Margin (5Y Avg)-29.75%
EPS Excl Extra (Annual)$4.69
CapEx CAGR (5Y)164.23%
Tangible BV CAGR (5Y)60.13%
26-Week Price Return-1.65%
Quick Ratio (Annual)6.41x
13-Week Price Return-13.78%
Total Debt / Equity (Annual)1.08x
Current Ratio (Quarterly)7.14x
Enterprise Value$4,006.882
Revenue / Share Growth (5Y)70.45%
Asset Turnover (TTM)0.65x
Book Value / Share Growth (5Y)29.30%
Revenue / Employee (Annual)$1
Inventory Turnover (Annual)5.09x
Pretax Margin (Annual)17.76%
Cash / Share (Annual)$14.25
3-Month Return Std Dev51.45%
Gross Margin (5Y Avg)64.56%
Net Income / Employee (TTM)$0
ROE (Last FY)40.22%
Net Interest Coverage (Annual)78.47x
EPS Basic Excl Extra (Annual)$4.69
P/FCF (TTM)24.36x
Receivables Turnover (TTM)6.65x
EV / Free Cash Flow (TTM)29.99x
Total Debt / Equity (Quarterly)1.08x
EPS Incl Extra (TTM)$4.68
Receivables Turnover (Annual)6.65x
ROI (TTM)22.01%
P/S Ratio (TTM)6.58x
Pretax Margin (5Y Avg)-33.98%
Revenue / Share (Annual)$14.94
Tangible BV / Share (Annual)$13.75
Forward P/E44.97x
Price vs S&P 500 (52W)3.88%
P/E Ratio (TTM)20.93x
EPS Growth TTM (YoY)362.68%
Year-to-Date Return-4.55%
5-Day Price Return6.33%
EPS Normalized (Annual)$4.69
ROA (5Y Avg)-5.43%
Net Profit Margin (Annual)31.43%
Month-to-Date Return16.80%
Cash Flow / Share (TTM)$-0.92
EBITD / Share (Annual)$2.69
Operating Margin (Annual)17.93%
LT Debt / Equity (Annual)1.06x
P/CF (TTM)20.65x
ROI (5Y Avg)-7.48%
P/E Excl Extra (TTM)20.93x
LT Debt / Equity (Quarterly)1.06x
EPS Basic Excl Extra (TTM)$4.68
P/TBV (Quarterly)8.82x
P/B Ratio (Annual)8.79x
Inventory Turnover (TTM)5.06x
Pretax Margin (TTM)17.76%
Book Value / Share (Annual)$13.81
Price vs S&P 500 (13W)-14.46%
Beta2.28x
P/FCF (Annual)29.81x
Revenue / Share (TTM)$14.79
ROE (TTM)53.88%
52-Week Low$81.92
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.15
4.15
4.15
4.15
Industry Peers — Electromedical Equipment(29)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
TMDXTransMedics Group, Inc. Common Stock | 6.58x | 88.21% | 59.92% | 17.93% | $109.12 |
MDTMedtronic plc | 3.13x | 3.01% | 65.16% | 17.00% | $85.65 |
MASIMasimo Corporation | 6.12x | 5.95% | 61.90% | 20.30% | $178.29 |
LIVNLivaNova PLC Ordinary Shares | 2.56x | 8.24% | 68.04% | 14.09% | $65.01 |
ITGRInteger Holdings Corporation | 1.63x | 11.55% | 27.39% | 11.90% | $88.37 |
AXGNAxogen, Inc. Common Stock | 7.92x | 14.93% | 74.31% | -3.49% | $37.37 |
CNMDCONMED Corporation | 0.88x | 9.77% | 54.59% | 7.46% | $37.91 |
BLFSBioLife Solutions Inc. | 10.59x | 14.87% | 64.56% | -17.26% | $20.85 |
INMDInMode Ltd. Ordinary Shares | 2.45x | 12.45% | 78.54% | 23.05% | $14.33 |
CBLLCeriBell, Inc. Common Stock | 8.68x | — | 87.89% | -65.57% | $20.74 |
CVCapsoVision, Inc. Common Stock | 21.95x | — | 52.92% | -188.25% | $5.40 |
About
TransMedics Group Inc develops the Organ Care System (OCS), a portable organ perfusion and monitoring platform that preserves donor organs in near-physiologic conditions outside the body. The company's technology addresses significant limitations of traditional cold storage preservation, potentially improving organ quality and transplant outcomes. As a commercial-stage medical technology company, TransMedics is expanding its organ preservation system across multiple transplant disease states.